0.10Open0.10Pre Close0 Volume516 Open Interest15.00Strike Price0.00Turnover90.37%IV13.82%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0998Delta0.0869Gamma172.90Leverage Ratio-0.0282Theta-0.0003Rho-17.25Eff Leverage0.0039Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet